{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T14:03:43Z","timestamp":1774533823139,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1038\/s41390-025-04210-x","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T08:54:05Z","timestamp":1752137645000},"page":"1023-1031","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Density of tertiary lymphoid structures predict clinical outcome in hepatoblastoma"],"prefix":"10.1038","volume":"99","author":[{"given":"Ruiwen","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhipeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yisu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faji","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qirong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yupeng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shizhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qixuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheyu","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hengjun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yijie","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"key":"4210_CR1","doi-asserted-by":"publisher","first-page":"10137","DOI":"10.3748\/wjg.v20.i29.10137","volume":"20","author":"D Ayllon Teran","year":"2014","unstructured":"Ayllon Teran, D. et al. Efficacy of neoadjuvant therapy and surgical rescue for locally advanced hepatoblastomas: 10 year single-center experience and literature review. World J. Gastroenterol. 20, 10137\u201311043 (2014).","journal-title":"World J. Gastroenterol."},{"key":"4210_CR2","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.jss.2019.06.064","volume":"244","author":"AM Waters","year":"2019","unstructured":"Waters, A. M., Mathis, M. S., Beierle, E. A. & Russell, R. T. A synopsis of pediatric patients with hepatoblastoma and Wilms tumor: NSQIP-P 2012\u20132016. J. Surg. Res. 244, 338\u2013342 (2019).","journal-title":"J. Surg. Res."},{"key":"4210_CR3","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.cld.2011.03.011","volume":"15","author":"N Hadzic","year":"2011","unstructured":"Hadzic, N. & Finegold, M. J. Liver neoplasia in children. Clin. Liver Dis. 15, 443\u2013462 (2011).","journal-title":"Clin. Liver Dis."},{"key":"4210_CR4","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1002\/lt.21654","volume":"14","author":"MJ Finegold","year":"2008","unstructured":"Finegold, M. J. et al. Liver tumors: pediatric population. Liver Transpl. 14, 1545\u20131556 (2008).","journal-title":"Liver Transpl."},{"key":"4210_CR5","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/hpb.12112","volume":"15","author":"BJ Allan","year":"2013","unstructured":"Allan, B. J. et al. Predictors of survival and incidence of hepatoblastoma in the paediatric population. HPB15, 741\u2013746 (2013).","journal-title":"HPB"},{"key":"4210_CR6","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1634\/theoncologist.5-6-445","volume":"5","author":"CE Herzog","year":"2000","unstructured":"Herzog, C. E., Andrassy, R. J. & Eftekhari, F. Childhood cancers: hepatoblastoma. Oncologist 5, 445\u2013453 (2000).","journal-title":"Oncologist"},{"key":"4210_CR7","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/cncr.10282","volume":"94","author":"JM Schnater","year":"2002","unstructured":"Schnater, J. M. et al. Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group. Cancer 94, 1111\u20131120 (2002).","journal-title":"Cancer"},{"key":"4210_CR8","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s00383-008-2169-x","volume":"24","author":"PJ Shukla","year":"2008","unstructured":"Shukla, P. J. et al. Hepatoblastoma: a single institutional experience of 18 cases. Pediatr. Surg. Int. 24, 799\u2013802 (2008).","journal-title":"Pediatr. Surg. Int."},{"key":"4210_CR9","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/S0959-8049(97)00095-6","volume":"33","author":"D von Schweinitz","year":"1997","unstructured":"von Schweinitz, D. et al. Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology. Eur. J. Cancer 33, 1243\u20131249 (1997).","journal-title":"Eur. J. Cancer"},{"key":"4210_CR10","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/S0929-6646(11)60048-X","volume":"110","author":"PK Tsay","year":"2011","unstructured":"Tsay, P. K. et al. Treatment outcomes for hepatoblastoma: experience of 35 cases at a single institution. J. Formos. Med. Assoc. 110, 322\u2013325 (2011).","journal-title":"J. Formos. Med. Assoc."},{"key":"4210_CR11","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","volume":"19","author":"C Saut\u00e8s-Fridman","year":"2019","unstructured":"Saut\u00e8s-Fridman, C., Petitprez, F., Calderaro, J. & Fridman, W. H. Tertiary lymphoid structures in the era of cancer immunotherapy. Nat. Rev. Cancer 19, 307\u2013325 (2019).","journal-title":"Nat. Rev. Cancer"},{"key":"4210_CR12","doi-asserted-by":"publisher","first-page":"e009232","DOI":"10.1136\/jitc-2024-009232","volume":"12","author":"YY Zhao","year":"2024","unstructured":"Zhao, Y. Y. et al. Density of tertiary lymphoid structures predicts clinical outcome in breast cancer brain metastasis. J. Immunother. Cancer 12, e009232 (2024).","journal-title":"J. Immunother. Cancer"},{"key":"4210_CR13","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1002\/cam4.4796","volume":"11","author":"F Ren","year":"2022","unstructured":"Ren, F. et al. Tertiary lymphoid structures in lung adenocarcinoma: characteristics and related factors. Cancer Med. 11, 2969\u20132977 (2022).","journal-title":"Cancer Med."},{"key":"4210_CR14","doi-asserted-by":"crossref","unstructured":"Zhang, C. et al. Localization and density of tertiary lymphoid structures associate with molecular subtype and clinical outcome in colorectal cancer liver metastases. J. Immunother. Cancer 11, e006425 (2023).","DOI":"10.1136\/jitc-2022-006425"},{"key":"4210_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-015-0431-3","volume":"13","author":"S Dushyanthen","year":"2015","unstructured":"Dushyanthen, S. et al. Relevance of tumor-infiltrating lymphocytes in breast cancer. BMC Med. 13, 202 (2015).","journal-title":"BMC Med."},{"key":"4210_CR16","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1158\/1078-0432.CCR-13-1877","volume":"20","author":"JR Webb","year":"2014","unstructured":"Webb, J. R. et al. Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer. Clin. Cancer Res. 20, 434\u2013444 (2014).","journal-title":"Clin. Cancer Res."},{"key":"4210_CR17","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1158\/1078-0432.CCR-14-2085","volume":"21","author":"L Zhang","year":"2015","unstructured":"Zhang, L. et al. Tumor-infiltrating lymphocytes genetically engineered with an inducible gene encoding interleukin-12 for the immunotherapy of metastatic melanoma. Clin. Cancer Res. 21, 2278\u20132288 (2015).","journal-title":"Clin. Cancer Res."},{"key":"4210_CR18","doi-asserted-by":"publisher","first-page":"e009243","DOI":"10.1136\/jitc-2024-009243","volume":"12","author":"TS Groen-van Schooten","year":"2024","unstructured":"Groen-van Schooten, T. S. et al. Mapping the complexity and diversity of tertiary lymphoid structures in primary and peritoneal metastatic gastric cancer. J. Immunother. Cancer 12, e009243 (2024).","journal-title":"J. Immunother. Cancer"},{"key":"4210_CR19","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/ni.3290","volume":"16","author":"S Finkin","year":"2015","unstructured":"Finkin, S. et al. Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma. Nat. Immunol. 16, 1235\u20131244 (2015).","journal-title":"Nat. Immunol."},{"key":"4210_CR20","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/imr.12405","volume":"271","author":"MC Dieu-Nosjean","year":"2016","unstructured":"Dieu-Nosjean, M. C. et al. Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers. Immunol. Rev. 271, 260\u2013275 (2016).","journal-title":"Immunol. Rev."},{"key":"4210_CR21","doi-asserted-by":"crossref","unstructured":"Ma, L. et al. Clinicopathological and prognostic value of tertiary lymphoid structures in lung cancer: a meta-analysis. Clin. Transl. Oncol. 27, 1092\u20131104 (2025).","DOI":"10.1007\/s12094-024-03677-0"},{"key":"4210_CR22","doi-asserted-by":"crossref","unstructured":"Xu, W. et al. Heterogeneity in tertiary lymphoid structures predicts distinct prognosis and immune microenvironment characterizations of clear cell renal cell carcinoma. J. Immunother. Cancer 11, e006667 (2023).","DOI":"10.1136\/jitc-2023-006667"},{"key":"4210_CR23","doi-asserted-by":"publisher","first-page":"107753","DOI":"10.1016\/j.pharmthera.2020.107753","volume":"221","author":"Y Xiao","year":"2021","unstructured":"Xiao, Y. & Yu, D. Tumor microenvironment as a therapeutic target in cancer. Pharm. Ther. 221, 107753 (2021).","journal-title":"Pharm. Ther."},{"key":"4210_CR24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/978-3-319-78127-3_6","volume":"1060","author":"AE Denton","year":"2018","unstructured":"Denton, A. E., Roberts, E. W. & Fearon, D. T. Stromal cells in the tumor microenvironment. Adv. Exp. Med Biol. 1060, 99\u2013114 (2018).","journal-title":"Adv. Exp. Med Biol."},{"key":"4210_CR25","doi-asserted-by":"crossref","unstructured":"Arneth, B. Tumor microenvironment.  Medicina (Kaunas, Lithuania) 56, 15\u201330 (2019).","DOI":"10.3390\/medicina56010015"},{"key":"4210_CR26","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1158\/2159-8290.CD-19-0680","volume":"10","author":"T Aoki","year":"2020","unstructured":"Aoki, T. et al. Single-cell transcriptome analysis reveals disease-defining T-cell subsets in the tumor microenvironment of classic Hodgkin lymphoma. Cancer Discov. 10, 406\u2013421 (2020).","journal-title":"Cancer Discov."},{"key":"4210_CR27","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","volume":"79","author":"DC Hinshaw","year":"2019","unstructured":"Hinshaw, D. C. & Shevde, L. A. The tumor microenvironment innately modulates cancer progression. Cancer Res. 79, 4557\u20134566 (2019).","journal-title":"Cancer Res."},{"key":"4210_CR28","doi-asserted-by":"publisher","first-page":"830","DOI":"10.3389\/fimmu.2017.00830","volume":"8","author":"JL Teillaud","year":"2017","unstructured":"Teillaud, J. L. & Dieu-Nosjean, M. C. Tertiary lymphoid structures: an anti-tumor school for adaptive immune cells and an antibody factory to fight cancer?. Front. Immunol. 8, 830 (2017).","journal-title":"Front. Immunol."},{"key":"4210_CR29","doi-asserted-by":"publisher","first-page":"e1051922","DOI":"10.1080\/2162402X.2015.1051922","volume":"4","author":"W Zhu","year":"2015","unstructured":"Zhu, W. et al. A high density of tertiary lymphoid structure B cells in lung tumors is associated with increased CD4(+) T cell receptor repertoire clonality. Oncoimmunology 4, e1051922 (2015).","journal-title":"Oncoimmunology"},{"key":"4210_CR30","doi-asserted-by":"publisher","first-page":"5994","DOI":"10.1158\/1078-0432.CCR-12-3497","volume":"19","author":"JY Shi","year":"2013","unstructured":"Shi, J. Y. et al. Margin-infiltrating CD20(+) B cells display an atypical memory phenotype and correlate with favorable prognosis in hepatocellular carcinoma. Clin. Cancer Res 19, 5994\u20136005 (2013).","journal-title":"Clin. Cancer Res"},{"key":"4210_CR31","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41568-022-00466-1","volume":"22","author":"CM Laumont","year":"2022","unstructured":"Laumont, C. M. et al. Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities. Nat. Rev. Cancer 22, 414\u2013430 (2022).","journal-title":"Nat. Rev. Cancer"},{"key":"4210_CR32","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/nri3857","volume":"15","author":"P Shen","year":"2015","unstructured":"Shen, P. & Fillatreau, S. Antibody-independent functions of B cells: a focus on cytokines. Nat. Rev. Immunol. 15, 441\u2013451 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"4210_CR33","doi-asserted-by":"publisher","first-page":"109422","DOI":"10.1016\/j.celrep.2021.109422","volume":"36","author":"AB Rodriguez","year":"2021","unstructured":"Rodriguez, A. B. et al. Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts. Cell Rep. 36, 109422 (2021).","journal-title":"Cell Rep."},{"key":"4210_CR34","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.cell.2018.01.004","volume":"172","author":"JP B\u00f6ttcher","year":"2018","unstructured":"B\u00f6ttcher, J. P. et al. NK cells stimulate recruitment of cDC1 into the tumor microenvironment promoting cancer immune control. Cell 172, 1022\u20131037.e14 (2018).","journal-title":"Cell"},{"key":"4210_CR35","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/s41591-018-0085-8","volume":"24","author":"KC Barry","year":"2018","unstructured":"Barry, K. C. et al. A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments. Nat. Med. 24, 1178\u20131191 (2018).","journal-title":"Nat. Med."},{"key":"4210_CR36","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.cell.2016.01.049","volume":"164","author":"AK Palucka","year":"2016","unstructured":"Palucka, A. K. & Coussens, L. M. The basis of oncoimmunology. Cell 164, 1233\u20131247 (2016).","journal-title":"Cell"},{"key":"4210_CR37","doi-asserted-by":"publisher","first-page":"1049884","DOI":"10.3389\/fimmu.2022.1049884","volume":"13","author":"Y An","year":"2022","unstructured":"An, Y. et al. Tertiary lymphoid structure patterns aid in identification of tumor microenvironment infiltration and selection of therapeutic agents in bladder cancer. Front. Immunol. 13, 1049884 (2022).","journal-title":"Front. Immunol."},{"key":"4210_CR38","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.1200\/JCO.2007.15.0284","volume":"26","author":"MC Dieu-Nosjean","year":"2008","unstructured":"Dieu-Nosjean, M. C. et al. Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. J. Clin. Oncol. 26, 4410\u20134417 (2008).","journal-title":"J. Clin. Oncol."},{"key":"4210_CR39","doi-asserted-by":"publisher","first-page":"293","DOI":"10.31083\/j.fbl2908293","volume":"29","author":"P Chaudhary","year":"2024","unstructured":"Chaudhary, P., Srivastava, P. & Manna, P. P. Effector functions of dendritic cells in cancer: role of cytotoxicity and growth inhibition. Front Biosci.29, 293 (2024).","journal-title":"Front Biosci."},{"key":"4210_CR40","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.3389\/fimmu.2019.01014","volume":"10","author":"R Noubade","year":"2019","unstructured":"Noubade, R., Majri-Morrison, S. & Tarbell, K. V. Beyond cDC1: emerging roles of DC crosstalk in cancer immunity. Front. Immunol. 10, 1014 (2019).","journal-title":"Front. Immunol."},{"key":"4210_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-64980-y","volume":"14","author":"Y Weng","year":"2024","unstructured":"Weng, Y. et al. The impact of tertiary lymphoid structures on tumor prognosis and the immune microenvironment in non-small cell lung cancer. Sci. Rep. 14, 16246 (2024).","journal-title":"Sci. Rep."},{"key":"4210_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-71775-4","volume":"10","author":"F Ghasemi","year":"2020","unstructured":"Ghasemi, F. et al. High MHC-II expression in Epstein-Barr virus-associated gastric cancers suggests that tumor cells serve an important role in antigen presentation. Sci. Rep. 10, 14786 (2020).","journal-title":"Sci. Rep."},{"key":"4210_CR43","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.1182\/blood-2003-07-2365","volume":"103","author":"LM Rimsza","year":"2004","unstructured":"Rimsza, L. M. et al. Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project. Blood 103, 4251\u20134258 (2004).","journal-title":"Blood"},{"key":"4210_CR44","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1002\/pbc.25118","volume":"61","author":"FA Leite","year":"2014","unstructured":"Leite, F. A. et al. Low expression of HLA-DRA, HLA-DPA1, and HLA-DPB1 is associated with poor prognosis in pediatric adrenocortical tumors (ACT). Pediatr. Blood Cancer 61, 1940\u20131948 (2014).","journal-title":"Pediatr. Blood Cancer"},{"key":"4210_CR45","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.3389\/fonc.2020.01245","volume":"10","author":"L Lyu","year":"2020","unstructured":"Lyu, L. et al. Overexpressed pseudogene HLA-DPB2 promotes tumor immune infiltrates by regulating HLA-DPB1 and indicates a better prognosis in breast cancer. Front Oncol. 10, 1245 (2020).","journal-title":"Front Oncol."},{"key":"4210_CR46","doi-asserted-by":"crossref","unstructured":"Zhong, M. C. et al. SLAM family receptors control pro-survival effectors in germinal center B cells to promote humoral immunity. J. Exp. Med. 218, e20200756 (2021).","DOI":"10.1084\/jem.20200756"},{"key":"4210_CR47","doi-asserted-by":"publisher","first-page":"eabj3286","DOI":"10.1126\/sciadv.abj3286","volume":"8","author":"MS Hasim","year":"2022","unstructured":"Hasim, M. S. et al. When killers become thieves: trogocytosed PD-1 inhibits NK cells in cancer. Sci. Adv. 8, eabj3286 (2022).","journal-title":"Sci. Adv."},{"key":"4210_CR48","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.immuni.2007.11.005","volume":"27","author":"A Veillette","year":"2007","unstructured":"Veillette, A., Dong, Z. & Latour, S. Consequence of the SLAM-SAP signaling pathway in innate-like and conventional lymphocytes. Immunity 27, 698\u2013710 (2007).","journal-title":"Immunity"},{"key":"4210_CR49","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1126\/science.aar4060","volume":"359","author":"A Ribas","year":"2018","unstructured":"Ribas, A. & Wolchok, J. D. Cancer immunotherapy using checkpoint blockade. Science 359, 1350\u20131355 (2018).","journal-title":"Science"},{"key":"4210_CR50","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/978-3-030-73119-9_3","volume":"1329","author":"MC Dieu-Nosjean","year":"2021","unstructured":"Dieu-Nosjean, M. C. Tumor-associated tertiary lymphoid structures: a cancer biomarker and a target for next-generation immunotherapy. Adv. Exp. Med. Biol. 1329, 51\u201368 (2021).","journal-title":"Adv. Exp. Med. Biol."},{"key":"4210_CR51","doi-asserted-by":"publisher","first-page":"674565","DOI":"10.3389\/fimmu.2021.674565","volume":"12","author":"M Tr\u00fcb","year":"2021","unstructured":"Tr\u00fcb, M. & Zippelius, A. Tertiary lymphoid structures as a predictive biomarker of response to cancer immunotherapies. Front. Immunol. 12, 674565 (2021).","journal-title":"Front. Immunol."},{"key":"4210_CR52","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1007\/s00262-007-0286-3","volume":"56","author":"A Lad\u00e1nyi","year":"2007","unstructured":"Lad\u00e1nyi, A. et al. Density of DC-LAMP(+) mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor. Cancer Immunol. Immunother. 56, 1459\u20131469 (2007).","journal-title":"Cancer Immunol. Immunother."},{"key":"4210_CR53","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1365-2249.2010.04147.x","volume":"161","author":"TP McMullen","year":"2010","unstructured":"McMullen, T. P. et al. Survival in rectal cancer is predicted by T cell infiltration of tumour-associated lymphoid nodules. Clin. Exp. Immunol. 161, 81\u201388 (2010).","journal-title":"Clin. Exp. Immunol."},{"key":"4210_CR54","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41586-019-1906-8","volume":"577","author":"F Petitprez","year":"2020","unstructured":"Petitprez, F. et al. B cells are associated with survival and immunotherapy response in sarcoma. Nature 577, 556\u2013560 (2020).","journal-title":"Nature"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04210-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04210-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04210-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T13:09:22Z","timestamp":1774530562000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04210-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4210"],"URL":"https:\/\/doi.org\/10.1038\/s41390-025-04210-x","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]},"assertion":[{"value":"7 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article. This retrospective study was approved by the Biomedical Ethics Committee of Shandong Prov incial Hospital (Approval No. SWYX2025-217). The need for informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}